Skip to main content

Table 1 Characteristics of the 92 patients at T0 according to plasma HIV viremia control (SSP, VP and PSP). Data are expressed as median and interquartile range (IQR)

From: Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study

  SSP (40 pts) VP (33 pts) SPS (19 pts)
Age (years) 47 (39–59 40 (32–47) 43 (38–49)
CD4 + cell count/mm3 605 (475–785) 570 (410–662) 530 (370–827)
CD4+ cell percentage 27.5 (22.5–36) 23 (19.7–30) 24 (20–28.2)
CD8+ cell count/mm 849 (602–1227) 1106 (1012–1464) 1240 (854–1490)
CD8 + cell percentage 43 (34.5–51) 51 (47–60) 48 (42–62)
CD4/CD8 ratio 0.8 (0.5–1) 0.4 (0.4–0.6) 0.6(0.3–0.7)
CD4+ cell count at nadir (cells/mm3) 290 (132–405) 460 (322–535) 260 (88–355)
Plasma HIV-RNA value in the 24 month prior T0 log (Log10 copies/ml) 4.57(3.99–4.8)
Plasma HIV-RNA value in the 24 month prior T1 (Log10 copies/ml) 4.44 (3.77–4.83)
  1. T0: time of the first saliva sampling after 24 months of plasma HIV RNA control analysis
  2. T1: time of the second saliva testing, 24 months after T0
  3. SSPs HIV successfully suppressed patients, VPs HIV viremic patients, PSPs HIV partially suppressed patients